AN2 Therapeutics Inc. has engaged in share transactions with Coastlands Capital Partners LP. On June 17, 2025, Coastlands Capital exchanged 2,500,000 shares of the company's common stock for a pre-funded warrant to acquire an equivalent number of shares. Similarly, on June 19, 2025, 300,000 shares of common stock were exchanged for a pre-funded warrant to acquire 300,000 shares. The pre-funded warrants have an exercise price of $0.00001 per share and are exercisable at any time until fully exercised.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-143187), on June 20, 2025, and is solely responsible for the information contained therein.